TILMIVET

Withdrawal period: The treated animals must not be sacrificed for human consumption before 8 days after the treatment has finished.

Actions: TILMIVET is a modern macrolide antibiotic based on tilmicosin of excellent activity against M. hyopneumoniae in pigs. Its absorption is high through the oral route, allowing its administration to through this route, either in drinking water or in food. It has an excellent diffusion to the fabrics especially in the fabric lung, and macrophages, thus allowing high concentrations to be reached tissues, which far exceed the minimum inhibitory concentration of these pathogens.

Indications: It is indicated for the treatment of respiratory diseases of pigs caused by Mycoplasma hyopneumoniae, Pasteurella multocida, Actinobacillus pleuropneumoniae. and other organisms sensitive to tilmicosin.

Dosages and application: The recommended dose in pigs is 10-20 mg / Kg of live weight. Other dosages under veterinary or zootechnician advice.

Ica register: 6540 MV